CHEK1 and hepatocellular carcinoma: Previous reports have demonstrated that it is overexpressed and associated with poor prognosis in HCC, suggesting that it is an oncogene and that CHEK1 is negatively regulated by miR-497 and providing a potential molecular target for HCC therapy [50].